Jessica Riggleman

Jessica is the Senior Director of Clinical and Regulatory Affairs for Mydecine Innovations Group. She has spent the last ten years in the clinical research industry and has worked closely with cross-functional teams to develop clinical evidence generation strategies for global indication submissions. Jessica has supported and published research in robotics, orthopedics, trauma, biologics, transcranial magnetic stimulation, and now psychedelic-assisted psychotherapy. She is enthusiastic about the future of integrative healing models in the United States healthcare system. Jessica received her graduate degree in Clinical Research Administration from George Washington University and resides in the Greater Philadelphia area in the United States.